FindTrial
Sign In

Postoperative hemolytic anemia caused by levofloxacin after breast augmentation: 1 rare complication case and literature review

Postoperative hemolytic anemia caused by levofloxacin after breast augmentation: 1 rare complication case and literature review

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087740
Enrollment
Unknown
Registered
2024-08-02
Start date
2024-05-28
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemolytic anemia

Interventions

1 patient:None

Sponsors

the First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
39 Years to 39 Years

Inclusion criteria

Inclusion criteria: On November 8, 2023, a female patient, a 39-year-old Asian woman, underwent "endoscopic breast augmentation surgery" at the Department of Plastic Surgery of the First Affiliated Hospital of Sun Yat-sen University. Levofloxacin was injected during and after breast augmentation surgery.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
hemoglobin;—

Countries

China

Contacts

Public ContactZhaowei Zhu

the First Affiliated Hospital of Sun Yat-Sen University

nmtmemoir@aliyun.com+86 150 9995 7400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026